Cargando…
A review on the importance of genotyping and phenotyping in fluoropyrimidine treatment
Fluoropyrimidines, after more than 50 years from their discovery, are still the treatment of many types of cancer, and it is estimated that two million patients receive fluoropyrimidine therapy annually. The toxicity associated with fluoropyrimidines affects 30–40% of patients and some adverse effec...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7418836/ https://www.ncbi.nlm.nih.gov/pubmed/32832886 http://dx.doi.org/10.15386/mpr-1564 |